Fluarix Quadrivalent
Payments companies reported to CMS as associated with Fluarix Quadrivalent. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Fluarix Quadrivalent, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Fluarix Quadrivalent
These are the largest totals companies reported as associated with Fluarix Quadrivalent. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sarah Bourland | San Antonio, TX | Pediatrics | $622.37 |
| Joan Purcell | The Woodlands, TX | Adolescent Medicine (Pediatrics) | $520.96 |
| Joseph Edralin | The Woodlands, TX | Pediatrics | $364.12 |
| Hanh Truong | Sugar Land, TX | Internal Medicine | $214.37 |
| Bochen Tong | Richmond, TX | Family Medicine | $164.88 |
| Dianna Burns | San Antonio, TX | Pediatrics | $157.91 |
| John Vanderzyl | Sugar Land, TX | Family Medicine | $141.81 |
| James Trippett | Sugar Land, TX | Family Medicine | $141.81 |
| Henry Mata | Sugar Land, TX | Family Medicine | $141.80 |
| Tracey Miller | Sugar Land, TX | Medical | $128.65 |
Prescribed Fluarix Quadrivalent?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.